Ketorolac After PRP Injection: Safety Recommendations
Direct Answer
You should avoid ketorolac (and all NSAIDs) for 7–14 days after your platelet-rich plasma injection to prevent interference with the healing mechanisms that PRP is intended to promote. 1
Rationale for NSAID Avoidance
NSAIDs theoretically interfere with platelet-derived growth factor activity, which is the primary mechanism by which PRP is thought to work. 1 The growth factors released from platelets are essential for the intended therapeutic effect, and NSAIDs may blunt this biological response.
Evidence Supporting NSAID Restriction
- 42.8% of clinical studies investigating PRP efficacy included postinjection NSAID restrictions, with durations ranging from 1 to 1800 days, though the most common restriction period was shorter-term. 2
- 51.9% of studies excluded patients who used NSAIDs within 5 days prior to PRP injection, suggesting concern about NSAID effects on the treatment. 2
- In vitro laboratory studies demonstrate that ketorolac combined with PRP maintains cell viability in both chondrocytes and tenocytes, suggesting ketorolac may not be directly toxic to these cells when combined with PRP. 3 However, this addresses cellular toxicity rather than the functional interference with growth factor signaling that is the primary concern.
Recommended Pain Management Alternative
Use acetaminophen (paracetamol) for pain control during the 7–14 day NSAID restriction period. 1 Acetaminophen does not interfere with platelet function or prostaglandin synthesis in the same manner as NSAIDs.
Important Context About PRP Therapy
Guideline Stance on PRP
It is important to note that major medical organizations strongly recommend against PRP for knee osteoarthritis:
- The American College of Rheumatology/Arthritis Foundation issues a strong recommendation against PRP due to lack of standardization, heterogeneity of preparations, and insufficient evidence of clinical benefit. 1, 4
- The American Academy of Orthopaedic Surgeons acknowledges limited evidence showing some pain reduction and functional improvement, but notes inconsistent results, particularly in severe osteoarthritis. 4
- Medicare does not cover PRP injections for knee osteoarthritis, reflecting the guideline-based position that the procedure lacks sufficient evidence of efficacy. 5, 1
When PRP Might Be Considered
If PRP is used, it should only be considered after failure of conservative treatments (physical therapy, exercise, weight management, oral/topical NSAIDs) and injectable corticosteroids, in patients ≤80 years old with mild-to-moderate (Kellgren-Lawrence grade 0-III) osteoarthritis. 1 PRP should not be used as first-line therapy or in severe (grade IV) disease. 1
Clinical Pitfalls to Avoid
- Do not use ketorolac or any NSAID for at least 7 days post-PRP injection, as this is the minimum restriction period recommended in guidelines. 1
- Be aware that ketorolac carries significant bleeding risks independent of PRP considerations, including effects on platelet aggregation and increased risk when combined with anticoagulants. 6
- Ketorolac should never be used for more than 5 days total due to gastrointestinal and renal toxicity risks. 6
- Patients with renal impairment, elderly patients, and those on anticoagulants face heightened risks with ketorolac use. 6